GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (STU:ZSB) » Definitions » EV-to-EBITDA

Sirona Biochem (STU:ZSB) EV-to-EBITDA : -7.92 (As of Apr. 27, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sirona Biochem EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sirona Biochem's enterprise value is €12.84 Mil. Sirona Biochem's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was €-1.62 Mil. Therefore, Sirona Biochem's EV-to-EBITDA for today is -7.92.

The historical rank and industry rank for Sirona Biochem's EV-to-EBITDA or its related term are showing as below:

STU:ZSB' s EV-to-EBITDA Range Over the Past 10 Years
Min: -58.74   Med: -11.34   Max: -3.03
Current: -7.92

During the past 13 years, the highest EV-to-EBITDA of Sirona Biochem was -3.03. The lowest was -58.74. And the median was -11.34.

STU:ZSB's EV-to-EBITDA is ranked worse than
100% of 472 companies
in the Biotechnology industry
Industry Median: 9.1 vs STU:ZSB: -7.92

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-27), Sirona Biochem's stock price is €0.042. Sirona Biochem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was €-0.005. Therefore, Sirona Biochem's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Sirona Biochem EV-to-EBITDA Historical Data

The historical data trend for Sirona Biochem's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem EV-to-EBITDA Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.22 -13.67 -20.57 -9.32 -9.93

Sirona Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.25 -16.49 -12.73 -9.93 -11.61

Competitive Comparison of Sirona Biochem's EV-to-EBITDA

For the Biotechnology subindustry, Sirona Biochem's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Biochem's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's EV-to-EBITDA falls into.



Sirona Biochem EV-to-EBITDA Calculation

Sirona Biochem's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=12.842/-1.622
=-7.92

Sirona Biochem's current Enterprise Value is €12.84 Mil.
Sirona Biochem's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sirona Biochem  (STU:ZSB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sirona Biochem's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.042/-0.005
=At Loss

Sirona Biochem's share price for today is €0.042.
Sirona Biochem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.005.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Sirona Biochem EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Biochem (STU:ZSB) Business Description

Traded in Other Exchanges
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (STU:ZSB) Headlines

No Headlines